Trinity Biotech reported 25.62M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8383M 448M
Bayer BAYN:GR 9.25B 3.88B
Bio Rad Laboratories BIO:US $ 590.24M 904K
Cytori Therapeutics CYTX:US $ 3.5M 924K
Edap Tms EDAP:US 11.32M 548K
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Mesa Laboratories MLAB:US $ 31.64M 158K
Orasure Technologies OSUR:US $ 66.93M 11.12M
Oxford Immunotec Global OXFD:US 19.16M 3.49M
Siemens SIE:GR 15.82B 1.4B
Sientra SIEN:US 31.31M 2.05M
Surmodics SRDX:US $ 24.46M 1.8M
Thermo Fisher Scientific TMO:US $ 7052M 58M
Tosoh 4042:JP 192.99B 21.6B
Trinity Biotech TRIB:US 25.62M 3.11M
Veracyte VCYT:US $ 77.05M 14.47M